Clinical trial

I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers

NCT02323217

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-01-01

PhaseEARLY_PHASE1

Study timeline

Study start (unknown)2015-01-01Date precision: month

Registry last updated2021-11-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Healthy Volunteersunresolved

Alzheimer Diseaseunresolved

Molecular Imagingunresolved

Interventions

[11C]BU99008RADIATION

IdazoxanDRUG

IsocarboxazidDRUG · verified · RxNorm: isocarboxazid

Sponsors & collaborators

Imperial College Londonlead sponsor

GlaxoSmithKlinecollaborator

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02323217 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.